NASDAQ
Lipella Pharmaceuticals Inc. (LIPO) has a free cash flow growth of -164417.43% as of Friday, May 29, 2026. This represents a 978359.35% decrease compared to its 12-month average of -16.80%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.